AKT1 and neoplasm: We identified 18 targets of the RA that participated in 20 KEGG pathways (Figure 3b), some of which were involved in anti-tumor signaling pathways such as metabolic pathways, the PI3K/Akt signaling pathway and the NF-κB signaling pathway.